Crossbow Therapeutics
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
$77MSeries B
Role not disclosedLV
LifeLink Ventures
Activity from announced rounds
All recorded activity
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $77M 1 disclosed · full round size, not this investor’s share